Funding Opportunities

• Non-Viral Technologies for in vivo Delivery of Genome Editors (R43/R44 Clinical Trial Not Allowed)
  (PAR-20-098)
  National Center for Advancing Translational Sciences
  National Center for Advancing Translational Sciences
  National Institute on Aging
  National Institute of Allergy and Infectious Diseases
  National Institute of General Medical Sciences
  National Institute of Neurological Disorders and Stroke
  Application Receipt Date(s): Standard dates apply The first standard due date for this FOA is April 5, 2020
• Biomedical Technology Development and Dissemination Center (RM1 - Clinical Trial Not Allowed)
  (PAR-20-104)
  National Institute of General Medical Sciences
  Application Receipt Date(s): May 26, 2020; January 26, 2021; May 26, 2021; January 26, 2022; May 26, 2022; January 26, 2023
• Laboratory Flexible Funding Model (LFFM) (U19) Clinical Trials Not Allowed
  (PAR-20-105)
  Food and Drug Administration
  Application Receipt Date(s): May 6, 2020 by 11:59 PM Eastern Time April 6, 2021 by 11:59 PM Eastern Time. April 6, 2022 by 11:59 PM Eastern Time. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. Applicants should be aware that on-time submission means that an application is submitted error free (of both Grants.gov and eRA Commons errors) by 11:59 PM Eastern Time on the application due date. Late applications will not be accepted for this FOA.
• Centers for AIDS Research (P30 Clinical Trial Not Allowed)
  (PAR-20-106)
  National Institute of Allergy and Infectious Diseases
  National Institute on Aging
  National Cancer Institute
  National Institute on Drug Abuse
  National Institute of Dental and Craniofacial Research
  National Institute of Diabetes and Digestive and Kidney Diseases
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Heart, Lung, and Blood Institute
  National Institute of Mental Health
  National Institute of Nursing Research
  John E. Fogarty International Center
  National Institute on Minority Health and Health Disparities
  Application Receipt Date(s): Only accepting applications for the AIDS Application Due Date(s) listed below.
• Developmental Centers for AIDS Research (P30 Clinical Trial Not Allowed)
  (PAR-20-107)
  National Institute of Allergy and Infectious Diseases
  National Institute on Aging
  National Cancer Institute
  National Institute on Drug Abuse
  National Institute of Dental and Craniofacial Research
  National Institute of Diabetes and Digestive and Kidney Diseases
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Heart, Lung, and Blood Institute
  National Institute of Mental Health
  National Institute of Nursing Research
  John E. Fogarty International Center
  National Institute on Minority Health and Health Disparities
  Application Receipt Date(s): Only accepting applications for the AIDS Application Due Date(s) listed below.
• International Research in Infectious Diseases (R01 Clinical Trial Not Allowed)
  (PAR-20-108)
  National Institute of Allergy and Infectious Diseases
  Application Receipt Date(s): July 15, 2020; July 15, 2021; July 15 2022
• Non-Viral Technologies for in vivo Delivery of Genome Editors (R41/R42 Clinical Trial Not Allowed)
  (PAR-20-109)
  National Center for Advancing Translational Sciences
  National Center for Advancing Translational Sciences
  National Institute on Aging
  National Institute of Allergy and Infectious Diseases
  National Institute of General Medical Sciences
  National Institute of Neurological Disorders and Stroke
  Application Receipt Date(s): Standard dates apply The first standard due date for this FOA is April 5, 2020
• National Institute on Aging Genetics of Alzheimer's Disease Data Storage Site (U24 Clinical Trial Not Allowed)
  (PAR-20-110)
  National Institute on Aging
  Application Receipt Date(s): Standard dates apply. The first standard due date for this FOA is May 25, 2020.
• Molecular Mechanisms of Combination Adjuvants (MMCA) (U01 Clinical Trial Not Allowed)
  (RFA-AI-20-004)
  National Institute of Allergy and Infectious Diseases
  Application Receipt Date(s): July 20, 2020
• Mentored Research Scientist Career Development Award in Tobacco Regulatory Research (K01 - Independent Clinical Trial Not Allowed)
  (RFA-OD-20-008)
  Office of Disease Prevention
  National Cancer Institute
  National Institute on Drug Abuse
  National Institute of Environmental Health Sciences
  National Heart, Lung, and Blood Institute
  Application Receipt Date(s): July 8, 2020, February 08, 2021, October 08, 2021, July 8, 2022) All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applications are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Pathway to Independence Award in Tobacco Regulatory Research (K99/R00 - Independent Clinical Trial Not Allowed)
  (RFA-OD-20-009)
  Office of Disease Prevention
  National Cancer Institute
  National Institute on Drug Abuse
  National Institute of Environmental Health Sciences
  National Heart, Lung, and Blood Institute
  Application Receipt Date(s): July 8, 2020, February 08, 2021, October 08, 2021, July 8, 2022 Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applications are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Pathway to Independence Award in Tobacco Regulatory Research (K99/R00 - Independent Clinical Trial Required)
  (RFA-OD-20-010)
  Office of Disease Prevention
  National Cancer Institute
  National Institute on Drug Abuse
  National Heart, Lung, and Blood Institute
  Application Receipt Date(s): July 8, 2020, February 08, 2021, October 08, 2021, July 8, 2022 All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applications are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Mentored Research Scientist Career Development Award in Tobacco Regulatory Research (K01 - Independent Clinical Trial Required)
  (RFA-OD-20-011)
  Office of Disease Prevention
  National Cancer Institute
  National Institute on Drug Abuse
  National Heart, Lung, and Blood Institute
  Application Receipt Date(s): July 8, 2020, February 08, 2021, October 08, 2021, July 8, 2022 All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applications are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.